Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF) - PubMed

NCT05321069.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov